Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
RECORD trial
Description:
A randomized clinical trial evaluating rosiglitazone’s cardiovascular outcomes and safety in people with type 2 diabetes.
Primary topic:
Diabetes Treatment and Management (40%)
Related topics:
Diabetes Treatment and Management (40%),
Venous Thromboembolism Diagnosis and Management (21%),
Vitamin D Research Studies (7%)
OpenAlex ID:
keywords/record-trial
Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial
2005
·
AM Grant
, FH Anderson
, et al.
·
The Lancet
·
1,046
Rosiglitazone Revisited: An Updated Meta-analysis of Risk for Myocardial Infarction and Cardiovascular Mortality
2010
·
Steven E. Nissen
, Kathy Wolski
·
Archives of Internal Medicine
·
656
Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data
2019
·
John M Dennis
, Beverley M Shields
, et al.
·
The Lancet Diabetes & Endocrinology
·
511
PDF
Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis , , ,
2014
·
John A Ford
, Graeme S MacLennan
, et al.
·
American Journal of Clinical Nutrition
·
300
PDF
Long-Term Follow-Up for Mortality and Cancer in a Randomized Placebo-Controlled Trial of Vitamin D3and/or Calcium (RECORD Trial)
2011
·
Alison Avenell
, Graeme S. MacLennan
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
252
PDF
Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial
2010
·
M. Komajda
, J. J.V. McMurray
, et al.
·
European Heart Journal
·
243
PDF
Allogeneic Blood Transfusions and Postoperative Infections After Total Hip or Knee Arthroplasty
2014
·
Richard Friedman
, Martin Homering
, et al.
·
Journal of Bone and Joint Surgery
·
241
Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials
2010
·
P. D. Home
, S. E. Kahn
, et al.
·
Diabetologia
·
189
PDF
Results of a reevaluation of cardiovascular outcomes in the RECORD trial
2013
·
Kenneth W. Mahaffey
, Gail Hafley
, et al.
·
American Heart Journal
·
174
PDF
Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol
2005
·
P. D. Home
, S. J. Pocock
, et al.
·
Diabetologia
·
155
PDF
Vitamin D supplementation and type 2 diabetes: a substudy of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438)
2009
·
A. Avenell
, J. A. Cook
, et al.
·
Age and Ageing
·
148
Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data
2018
·
John M. Dennis
, William E. Henley
, et al.
·
Diabetes Care
·
145
PDF
The Record on Rosiglitazone and the Risk of Myocardial Infarction
2007
·
Bruce M. Psaty
, Curt D. Furberg
·
New England Journal of Medicine
·
130
PDF
Vitamin D supplementation to prevent infections: a sub-study of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438)
2007
·
A. Avenell
, J. A. Cook
, et al.
·
Age and Ageing
·
114
The rise and fall of rosiglitazone
2010
·
S. E. Nissen
·
European Heart Journal
·
96
Tumor Growth Rate Provides Useful Information to Evaluate Sorafenib and Everolimus Treatment in Metastatic Renal Cell Carcinoma Patients: An Integrated Analysis of the TARGET and RECORD Phase 3 Trial Data
2013
·
Charles Ferté
, Serge Koscielny
, et al.
·
European Urology
·
87
Rosiglitazone RECORD study: glucose control outcomes at 18 months
2007
·
P. D. Home
, N. P. Jones
, et al.
·
Diabetic Medicine
·
85
PDF
Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone
2008
·
Issa J Dahabreh
, K Economopoulos
·
Clinical Trials
·
63
Rivaroxaban – an oral, direct Factor Xa inhibitor – lessons from a broad clinical study programme
2009
·
Sylvia Haas
·
European Journal Of Haematology
·
62
PDF
Cost Effectiveness of Rivaroxaban versus Enoxaparin for Prevention of Post-Surgical Venous Thromboembolism from a US Payerʼs Perspective
2011
·
Aurea Duran
, Nishan Sengupta
, et al.
·
PharmacoEconomics
·
45
Viewpoint: Central adjudication of myocardial infarction in outcome-driven clinical trials – Common patterns in TRITON, RECORD, and PLATO?
2012
·
Dan Atar
, Victor L. Serebruany
·
Thrombosis and Haemostasis
·
41
Everolimus – a new approach in the treatment of renal cell carcinoma
2010
·
Tim Eisen
·
Cancer Management and Research
·
41
PDF
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
2010
·
S. Schinner
·
Yearbook of Endocrinology
·
38
Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty
2014
·
Bennett Levitan
, Zhong Yuan
, et al.
·
Vascular Health and Risk Management
·
37
PDF
Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal
2009
·
M Stevenson
, A Scope
, et al.
·
Health Technology Assessment
·
37
Show more works
View as search
Works count:
139
Citation count:
5,600
Year
Topic
Type